Autoimmune Sclerosing Cholangitis in Children: A Prospective Case-Control Study.

Area of Science:

• Pediatric Gastroenterology
• Hepatology
• Autoimmune Liver Diseases

Background:

• Autoimmune hepatitis (AIH) can overlap with primary sclerosing cholangitis, termed autoimmune sclerosing cholangitis (ASC).
• Previous studies using ERCP indicated a high prevalence of ASC in children.
• The utility of MRC for diagnosing ASC in pediatric AIH requires further investigation.

Purpose of the Study:

• To determine the prevalence of ASC in children with AIH using MRC.
• To compare the clinical presentation and outcomes of AIH and ASC in pediatric patients.
• To assess the prevalence of ASC in children with non-AIH cirrhosis.

Main Methods:

• Prospective study involving MRC in 38 children with AIH and 19 disease controls (Wilson disease).
• ASC diagnosis based on multiple biliary strictures and proximal dilatation identified via MRC.
• Detailed recording of clinical, laboratory, histopathological data, and treatment responses.

Main Results:

• Definite ASC changes were observed in 10.5% of children with AIH.
• No significant differences in clinical, laboratory, histological parameters, or treatment response between ASC and AIH groups.
• Abnormal MRC findings were noted in 36.8% of AIH cases and 42.1% of controls.

Conclusions:

• The prevalence of ASC in pediatric AIH is 10.5% when diagnosed by MRC.
• Suggests selective use of MRC for children with AIH presenting with cholestatic features, inflammatory bowel disease, or poor immunosuppression response.
• Highlights the importance of advanced imaging in diagnosing overlapping autoimmune liver conditions in children.